1.0Malaysian Tribunehttps://malaysiantribune.comadminhttps://malaysiantribune.com/author/admin/rich600338<blockquote class="wp-embedded-content" data-secret="Pw9Dz7GsmH"><a href="https://malaysiantribune.com/junshi-biosciences-announces-ongericimab-anti-pcsk9-mab-met-primary-endpoints-in-two-phase-3-clinical-studies/">Junshi Biosciences Announces Ongericimab (anti-PCSK9 mAb) Met Primary Endpoints in Two Phase 3 Clinical Studies</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://malaysiantribune.com/junshi-biosciences-announces-ongericimab-anti-pcsk9-mab-met-primary-endpoints-in-two-phase-3-clinical-studies/embed/#?secret=Pw9Dz7GsmH" width="600" height="338" title="“Junshi Biosciences Announces Ongericimab (anti-PCSK9 mAb) Met Primary Endpoints in Two Phase 3 Clinical Studies” — Malaysian Tribune" data-secret="Pw9Dz7GsmH" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> SHANGHAI, China, Feb. 27, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announced the successful completion of two randomized, double-blind, placebo-controlled, multi-center phase III clinical studies (Study nos.: JS002-003 and JS002-006) evaluating […]https://ci5.googleusercontent.com/proxy/3-ZhbWS7VZumAFG-sXhhf2fzbwnzFrmBUSnEimxgopRJSdfQPqjHppBIIePgZ05UjR6O9k8Vp9ysmUgTky09Lc0VVBdwO6GAnX9RbdO_1iAJska1H_-ZkFhwur1Udfwg=s0-d-e1-ft#https://www.globenewswire.com/newsroom/ti?nf=ODc3ODAzMyM1NDMzODQwIzIxOTUzNzU=